Form 4: Elevance Health Executive Ratnakar Lavu Reports Stock Transactions
SEC Form 4 Filing
Elevance Health's EVP, Chief Digital & Info Officer Ratnakar Lavu reports the acquisition and disposal of company stock and stock options.
Summary
- Ratnakar Lavu, EVP, Chief Digital & Info Officer of Elevance Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Lavu disposed of 312 shares of common stock to cover tax liabilities at a price of $395.5 per share.
- On the same day, Lavu acquired 2,339 restricted share units.
- Following these transactions, Lavu directly owns 4,783 shares of common stock.
- Lavu also acquired options to purchase 8,902 shares of common stock, exercisable in installments beginning March 3, 2026.
- Following these transactions, Lavu directly owns 8,902 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as the filing reflects routine transactions related to executive compensation. The acquisition of restricted stock units and options is a positive sign, but the disposal of shares for tax purposes is neutral.
Positives
- The acquisition of restricted share units and stock options indicates confidence in the company's future performance.
Negatives
- The disposal of shares to cover tax liabilities, while routine, slightly reduces Lavu's direct holdings.
Future Outlook
The vesting schedule of the restricted share units (779 shares on 3/3/2026, and 780 shares each on 3/3/2027 and 3/3/2028) and the exercisability of the stock options (starting 3/3/2026) suggest a long-term incentive plan for the executive.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices are typical for such equity-based compensation plans.
- Comparing Lavu's holdings and transactions to those of executives at similar healthcare companies (e.g., UnitedHealth Group, CVS Health) could provide further context.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- However, transparency in executive compensation and stock ownership is important for maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of stock disposal and acquisition of restricted share units and stock options. |
| 03/03/2026 | First vesting date for 779 restricted share units and first exercisable date for 2,967 stock options. |
| 03/03/2027 | Second vesting date for 780 restricted share units. |
| 03/03/2028 | Third vesting date for 780 restricted share units. |
| 03/03/2035 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.